We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$3.15B
AUM Growth
+$209M
Cap. Flow
+$45.8M
Cap. Flow %
1.45%
Top 10 Hldgs %
50.35%
Holding
67
New
21
Increased
15
Reduced
10
Closed
18

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$121M
2
TMO icon
Thermo Fisher Scientific
TMO
+$117M
3
DGX icon
Quest Diagnostics
DGX
+$104M
4
ELV icon
Elevance Health
ELV
+$94.1M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$56.8M

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$145M
2
MD icon
Pediatrix Medical
MD
+$76.9M
3
A icon
Agilent Technologies
A
+$70.5M
4
ABBV icon
AbbVie
ABBV
+$54.3M
5
IQV icon
IQVIA
IQV
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 87.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$321B
$254M 8.06%
4,385,000
+551,605
+14% +$31.1M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$77.4B
$216M 6.85%
625,000
– –
ZBH icon
3
Zimmer Biomet
ZBH
$18.4B
$215M 6.81%
1,982,750
-412,000
-17% -$44.8M
LH icon
4
Labcorp
LH
$25.9B
$162M 5.13%
1,047,600
-174,600
-14% -$26.4M
ELV icon
5
Elevance Health
ELV
$81.6B
$161M 5.1%
675,000
+406,230
+151% +$94.1M
BAX icon
6
Baxter International
BAX
$13.8B
$133M 4.22%
1,800,000
-324,670
-15% -$22.9M
HCA icon
7
HCA Healthcare
HCA
$85.7B
$123M 3.91%
+1,200,000
New +$121M
TMO icon
8
Thermo Fisher Scientific
TMO
$214B
$114M 3.62%
+550,000
New +$117M
DGX icon
9
Quest Diagnostics
DGX
$25.9B
$110M 3.48%
+997,580
New +$104M
UNH icon
10
UnitedHealth
UNH
$383B
$99.8M 3.17%
406,900
-213,580
-34% -$51.3M
PCRX icon
11
Pacira BioSciences
PCRX
$1.06B
$91.5M 2.91%
2,855,213
+555,213
+24% +$19.2M
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$88.8M 2.82%
1,314,290
+114,290
+10% +$6.39M
ISRG icon
13
Intuitive Surgical
ISRG
$126B
$84.2M 2.67%
528,030
-319,230
-38% -$48.7M
LIVN icon
14
LivaNova
LIVN
$4.45B
$79.9M 2.54%
800,000
-275,000
-26% -$25M
NBIX icon
15
Neurocrine Biosciences
NBIX
$18.7B
$78M 2.48%
793,955
+102,360
+15% +$9.16M
CELG
16
DELISTED
Celgene Corp
CELG
$75.7M 2.4%
952,670
+271,640
+40% +$22.6M
MASI
17
DELISTED
Masimo
MASI
$72.9M 2.32%
747,040
+172,040
+30% +$16.4M
MDT icon
18
Medtronic
MDT
$110B
$64M 2.03%
747,270
+628,150
+527% +$52.5M
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$60.4M 1.92%
+486,300
New +$56.8M
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
$59.7M 1.89%
2,025,000
+125,000
+7% +$3.95M
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$122B
$58.7M 1.86%
345,550
+195,760
+131% +$30.3M
DXCM icon
22
DexCom
DXCM
$28.8B
$58.4M 1.85%
+2,458,520
New +$52.1M
MDGL icon
23
Madrigal Pharmaceuticals
MDGL
$11.4B
$55.2M 1.75%
+197,281
New +$34.6M
QGEN icon
24
Qiagen
QGEN
$8.55B
$52.2M 1.66%
1,360,735
-531,827
-28% -$19.6M
DHR icon
25
Danaher
DHR
$138B
$50.2M 1.59%
573,396
-67,263
-10% -$5.99M
1
2 3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2018 Portfolio in Review

As of Q2 2018, HealthCor Management held 67 positions worth $3.15B, up 7.1% from $2.94B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

HealthCor Management's Q2 2018 filing shows 21 new, 15 increased, 10 reduced and 18 closed positions. Its largest new stake was HCA Healthcare: 1,200,000 shares worth $123M. The largest sale was Dentsply Sirona, an estimated $145M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 90% a quarter earlier.

  • HealthCor Management's largest Q2 2018 buy was HCA Healthcare: 1,200,000 shares worth $123M.
  • HealthCor Management added most to Elevance Health in Q2 2018, an estimated $94.1M increase.
  • HealthCor Management's biggest Q2 2018 reduction was UnitedHealth, cutting an estimated $51.3M.
  • HealthCor Management fully exited Dentsply Sirona in Q2 2018, selling an estimated $145M.
  • HealthCor Management's ten largest holdings make up 50% of its $3.15B portfolio in Q2 2018.
  • HealthCor Management opened 21 new positions and closed 18 in Q2 2018.
  • HealthCor Management's portfolio value rose 7.1% quarter-over-quarter to $3.15B.

Based on HealthCor Management's 13F filing for Q2 2018, filed 14 Aug 2018.